Recombinant rat fibroblast growth factor-16: Structure and biological activity

被引:17
作者
Danilenko, DM
Montestruque, S
Philo, JS
Li, TS
Hill, D
Speakman, J
Bahru, M
Zhang, MS
Konishi, O
Itoh, N
Chirica, M
Delaney, J
Hernday, N
Martin, F
Hara, S
Talvenheimo, J
Narhi, LO
Arakawa, T
机构
[1] Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA
[2] Kyoto Univ, Fac Pharmaceut Sci, Dept Biochem Genet, Kyoto 60601, Japan
关键词
FGF; protein structure; FTIR; CD; protein purification;
D O I
10.1006/abbi.1998.0967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factor-16 (FGF-16) is the most recent member of the FGF family to be cloned. Since the biologic activity of rat FGF-16 (rFGF-16) was unknown, and this protein has no apparent signal sequence, we transformed its entire cDNA into Escherichia coli for high-level expression and further characterization of this novel protein. an attempt was made to purify the expressed protein from the supernatant of mechanically lysed cells using sequential cation-exchange chromatography. This resulted in a gradual loss of the protein as precipitate throughout the purification process. In addition to precipitation during purification, sodium dodecyl sulfate polyacrylamide gel electrophoresis revealed that the partially purified materials showed a cluster of protein bands around 20k to 29k. Sequence analysis of the major bands indicated that two N-terminal truncations had occurred, during E. coli fermentation, purification, or both. The largest truncation resulted in the removal of the 34 N-terminal amino acids, including the initiation codon methionine. We cloned d34 rFGF-16, expressed the gene in E. coli, and developed a purification process for this form. Even with this truncated form, precipitation was a problem. We were largely able to overcome this problem, however, by including EDTA throughout the purification process. We have characterized the structure of purified d34 rFGF-16 extensively using circular dichroism, Fourier transform infrared spectroscopy, and sedimentation velocity analysis. These studies revealed that the protein has a distinct tertiary structure, consists primarily of beta-strands, has a weak tendency to self-associate, and is fairly extended. We then performed biologic assays which showed that d34 rFGF-16 induces oligodendrocyte proliferation in vitro, and induces hepatocellular proliferation and increased liver weight in vivo. Tn summaryZ FGF-16, a novel FGF family member, has both unique structural and biological properties. (C) 1999 Academic Press.
引用
收藏
页码:34 / 46
页数:13
相关论文
共 28 条
[1]   PRODUCTION AND CHARACTERIZATION OF AN ANALOG OF ACIDIC FIBROBLAST GROWTH-FACTOR WITH ENHANCED STABILITY AND BIOLOGICAL-ACTIVITY [J].
ARAKAWA, T ;
HORAN, TP ;
NARHI, LO ;
REES, DC ;
SCHIFFER, SG ;
HOLST, PL ;
PRESTRELSKI, SJ ;
TSAI, LB ;
FOX, GM .
PROTEIN ENGINEERING, 1993, 6 (05) :541-546
[2]   THE IMPORTANCE OF ARG40 AND ARG45 IN THE MITOGENIC ACTIVITY AND STRUCTURAL STABILITY OF BASIC FIBROBLAST GROWTH-FACTOR - EFFECTS OF ACIDIC AMINO-ACID SUBSTITUTIONS [J].
ARAKAWA, T ;
HOLST, P ;
NARHI, LO ;
PHILO, JS ;
WEN, J ;
PRESTRELSKI, SJ ;
ZHU, XT ;
REES, DC ;
FOX, GM .
JOURNAL OF PROTEIN CHEMISTRY, 1995, 14 (05) :263-274
[3]   CHARACTERIZATION OF A CYSTEINE-FREE ANALOG OF RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH-FACTOR [J].
ARAKAWA, T ;
HSU, YR ;
SCHIFFER, SG ;
TSAI, LB ;
CURLESS, C ;
FOX, GM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (01) :335-341
[4]   PREFERENTIAL INTERACTIONS OF PROTEINS WITH SALTS IN CONCENTRATED-SOLUTIONS [J].
ARAKAWA, T ;
TIMASHEFF, SN .
BIOCHEMISTRY, 1982, 21 (25) :6545-6552
[5]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[6]   ISOLATION, CHARACTERIZATION AND TISSUE LOCALIZATION OF AN N-TERINAL-TRUNCATED VARIANT OF FIBROBLAST GROWTH-FACTOR [J].
BERTOLINI, J ;
HEARN, MTW .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1987, 51 (03) :187-199
[7]   STRATEGIES TO SUPPRESS AGGREGATION OF RECOMBINANT KERATINOCYTE GROWTH-FACTOR DURING LIQUID FORMULATION DEVELOPMENT [J].
CHEN, BL ;
ARAKAWA, T ;
HSU, E ;
NARHI, LO ;
TRESSEL, TJ ;
CHIEN, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1657-1661
[8]  
FALCO JP, 1988, ONCOGENE, V2, P573
[9]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[10]  
FOX GM, 1988, J BIOL CHEM, V263, P18452